Altynai Satylganova Selected Research

Weight Gain

1/2020

Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Altynai Satylganova Research Topics

Disease

4	Weight Loss (Weight Reduction) 12/2021 - 01/2020
3	Obesity 12/2021 - 01/2020
2	Overweight 12/2021 - 01/2020
1	Nausea 12/2021
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2020
1	Weight Gain 01/2020

Drug/Important Bio-Agent (IBA)

3	Liraglutide FDA Link 12/2021 - 01/2020
2	cagrilintideIBA 12/2021 - 01/2021
1	GoldIBA 01/2021
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2020
1	Insulin (Novolin)FDA Link 01/2020

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2021
1	Glycemic Control 01/2020